|
|
||||||||
Ann Thorac Surg 1998;65:1625-1630
© 1998 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, University Hospitals in Lund, Sweden
b Department of Thoracic and Cardiovascular Surgery, University Hospitals, Linköping, Sweden
Accepted for publication January 21, 1998.
Address reprint requests to Dr Koul, Department of Thoracic and Cardiovascular Surgery, University Hospital, 221 85 Lund, Sweden
Background. Because of the limited supply of donor hearts, prospective recipients continue to die while on the waiting list for heart transplantation. Use of long-term mechanical circulatory support devices as a bridge to transplantation may reduce this mortality. However, with the present state of technology, continued clinical evaluation of the various long-term, mechanical circulatory support devices available is mandatory.
Methods. Sixteen patients were bridged with the HeartMate left ventricular assist device (LVAD) to heart transplantation for New York Heart Association functional class IV cardiac failure. Twelve pneumatic and six electric devices were used. The mean cardiac index and the mean pulmonary vascular resistance of the patient cohort were 1.7 1 · min-1 · m-2 and 3.1 Wood units, respectively.
Results. The mean LVAD support time per transplanted patient was 237 days, with a cumulative LVAD support time of about 7.2 years. Bleeding was the main operative and postoperative complication. Two patients suffered from neurologic complications and there were two major incidents of device malfunction. Twelve patients (75%) now have received a transplant, 3 (19%) are awaiting a transplant, and in 1 patient (6%), the device was explanted after spontaneous left ventricular recovery. Eleven of the 12 patients who received a transplant are alive and doing well. The HeartMate LVAD gave adequate circulatory support over extended periods of time and reversed the vital organ dysfunction. Since the start of the LVAD program, only 1 patient has died on our heart transplantation waiting list, compared to nine deaths in the 2 preceding years.
Conclusions. The HeartMate LVAD bridge to heart transplantation can be performed with low post-LVAD implantation and posttransplantation mortality and offers 1- and 2-year posttransplantation actuarial survival rates comparable to those for nonbridged heart transplant recipients.
This article has been cited by other articles:
![]() |
D. E. Jaroszewski, J. J. Lackey, L. A. Lanza, P. A. DeValeria, and F. A. Arabia Use of an Inexpensive Blue Band During Ventricular Assist Device and Total Artificial Heart Placement Facilitates and Expedites Explantation During Heart Transplant Ann. Thorac. Surg., May 1, 2009; 87(5): 1623 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Patel, E. S. Weiss, J. Schaffer, S. L. Ullrich, D. C. Rivard, A. S. Shah, S. D. Russell, and J. V. Conte Right Heart Dysfunction After Left Ventricular Assist Device Implantation: A Comparison of the Pulsatile HeartMate I and Axial-Flow HeartMate II Devices Ann. Thorac. Surg., September 1, 2008; 86(3): 832 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kartha, W. Gomez, B. Wu, and K. Tremper Laparoscopic cholecystectomy in a patient with an implantable left ventricular assist device Br. J. Anaesth., May 1, 2008; 100(5): 652 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liden, K. Karason, C.-H. Bergh, F. Nilsson, B. Koul, and L. Wiklund The feasibility of left ventricular mechanical support as a bridge to cardiac recovery Eur J Heart Fail, May 1, 2007; 9(5): 525 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Lazar, P. A. Shapiro, B. E. Jaski, M. K. Parides, R. C. Bourge, J. T. Watson, L. Damme, W. Dembitsky, J. D. Hosenpud, L. Gupta, et al. Neurological Events During Long-Term Mechanical Circulatory Support for Heart Failure: The Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Experience Circulation, May 25, 2004; 109(20): 2423 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Nabavi, J. Stockmann, C. Schmid, M. Schneider, D. Hammel, H. H. Scheld, and E. B. Ringelstein Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 160 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Thomas, D. Jichici, R. Petrucci, V. C. Urrutia, and R. J. Schwartzman Neurologic complications of the Novacor left ventricular assist device Ann. Thorac. Surg., October 1, 2001; 72(4): 1311 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koster, M. Loebe, R. Hansen, E. V. Potapov, G. P. Noon, H. Kuppe, and R. Hetzer Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow micromed DeBakey LVAD Ann. Thorac. Surg., August 1, 2000; 70(2): 533 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.W. Quinn, T.J.J. Jones, and T.R. Graham Mechanical Circulatory Support Sources of Emboli and Neurological Outcome Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 115 - 120. [Abstract] [PDF] |
||||
![]() |
U. W. Kjellman, P. Hallgren, C.-H. Bergh, J. Lycke, A. Oldfors, and L. Wiklund Weaning from mechanical support in a patient with acute heart failure and multiple sclerosis Ann. Thorac. Surg., February 1, 2000; 69(2): 628 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Arusoglu, R. Koerfer, G. Tenderich, W. A. Alexander, and A. El-Banayosy A novel method to reduce device-related infections in patients supported with the HeartMate device Ann. Thorac. Surg., November 1, 1999; 68(5): 1875 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Savage, T. A. d'Amato, and J. A. Magovern Aortic valve patch closure: an alternative to replacement with HeartMate(R) LVAS insertion Eur J Cardiothorac Surg, September 1, 1999; 16(3): 359 - 361. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |